News

But there’s another, lesser-known risk that can have lasting – and sometimes permanent – consequences: hearing loss. A wide ...
But there’s another, lesser-known risk that can have lasting – and sometimes permanent – consequences: hearing loss. A wide ...
Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.
A U.S. federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
Discover how bedtime antihypertensive dosing benefits blood pressure control. Keep reading for clinical insights and ...
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation (CDSCO) has flagged 130 drug samples as Not ...
The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from liver failure after taking it or a similar treatment.
A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...